{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:27:26Z","timestamp":1762864046343},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2001,12,1]],"date-time":"2001-12-01T00:00:00Z","timestamp":1007164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Opinion in Biotechnology"],"published-print":{"date-parts":[[2001,12]]},"DOI":"10.1016\/s0958-1669(01)00270-1","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T10:21:15Z","timestamp":1027592475000},"page":"622-625","source":"Crossref","is-referenced-by-count":57,"title":["Functional genomics and target validation approaches using antisense oligonucleotide technology"],"prefix":"10.1016","volume":"12","author":[{"given":"Nicholas M","family":"Dean","sequence":"first","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0958-1669(01)00270-1_BIB1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/nbt1297-1318","article-title":"The role of innovation in drug development","volume":"15","author":"Drews","year":"1997","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/90765","article-title":"Drug discovery \u2014 an operating model for a new era","volume":"19","author":"Myers","year":"2001","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB3","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB4","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1126\/science.1058040","article-title":"The sequence of the human genome","volume":"291","author":"Venter","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S0092-8674(01)00467-6","article-title":"A comparison of the Celera and Ensembl predicted gene sets reveals little overlap in novel genes","volume":"106","author":"Hogenesch","year":"2001","journal-title":"Cell"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB6","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB7","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/73439","article-title":"A gene expression database for the molecular pharmacology of cancer","volume":"24","author":"Scherf","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB8","first-page":"5403","article-title":"A public database for gene expression in human cancers","volume":"59","author":"Lal","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB9","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1073\/pnas.111153698","article-title":"Recursive partitioning for tumor classification with gene expression microarray data","volume":"98","author":"Zhang","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80867-3","article-title":"The impact of comparative genomics on our understanding of evolution","volume":"101","author":"Koonin","year":"2000","journal-title":"Cell"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB11","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/35015694","article-title":"Protein function in the post-genomic era","volume":"405","author":"Eisenberg","year":"2000","journal-title":"Nature"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB12","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1126\/science.1064621","article-title":"Pathway databases: a case study in computational symbolic theories","volume":"293","author":"Karp","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB13","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1126\/science.292.5518.929","article-title":"Integrated genomic and proteomic analyses of a systematically perturbed metabolic network","volume":"292","author":"Ideker","year":"2001","journal-title":"Science"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/35015701","article-title":"Genomics, gene expression and DNA arrays","volume":"405","author":"Lockhart","year":"2000","journal-title":"Nature"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB15","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/35015709","article-title":"Proteomics to study genes and genomes","volume":"405","author":"Pandey","year":"2000","journal-title":"Nature"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB16","series-title":"Antisense Drug Technology \u2013 Principles, Strategies and Applications","first-page":"1","article-title":"Basic principles of antisense technology","author":"Crooke","year":"2001"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB17","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1074\/jbc.274.3.1715","article-title":"Characterization of a potent and specific class of antisense oligonucleotide inhibitor of human protein kinase C-\u03b1 expression","volume":"274","author":"McKay","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB18","series-title":"Antisense Drug Technology \u2013 Principles, Strategies and Applications","first-page":"319","article-title":"Pharmacology of 2\u2032-O-(2-methoxy)etyl-modified antisense oligonucleotides","author":"Dean","year":"2001"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/35075107","article-title":"Initiation of a G2\/M checkpoint after ultraviolet radiation requires p38 kinase","volume":"411","author":"Bulavin","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB20","doi-asserted-by":"crossref","first-page":"27638","DOI":"10.1074\/jbc.M103512200","article-title":"Identification of an estrogen-inducible phosphatase PP5 that converts MCF-7 human breast carcinoma cells into an estrogen-independent phenotype when expressed constitutively","volume":"276","author":"Urban","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB21","first-page":"2105","article-title":"p27Kip1 is required for PTEN-induced G1 growth arrest","volume":"61","author":"Gottschalk","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB22","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1074\/jbc.M100819200","article-title":"A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis","volume":"276","author":"Bannerman","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/70242","article-title":"Pleiotropic cell-division defects and apoptosis induced by interference with survivin defects and apoptosis induced by interference with survivin function","volume":"1","author":"Li","year":"1999","journal-title":"Nat Cell Biol"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB24","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1038\/sj.onc.1202836","article-title":"Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli","volume":"18","author":"Taylor","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/85613","article-title":"Piecing together the significance of splicing","volume":"19","author":"Sorek","year":"2001","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB26","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1038\/15079","article-title":"Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides","volume":"17","author":"Taylor","year":"1999","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB27","first-page":"147","article-title":"Regulation of pre-mRNA splicing by antisense oligonucleotides","volume":"2","author":"Taylor","year":"1999","journal-title":"Curr Opin Drug Discovery Dev"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB28","series-title":"Antisense Drug Technology \u2013 Principles, Strategies and Applications","first-page":"517","article-title":"Pre-mRNA splicing as a target for antisense oligonucleotides","author":"Kole","year":"2001"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB29","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/nar\/29.6.1293","article-title":"Fully modified 2\u2032MOE oligonucleotides redirect polyadenylation","volume":"29","author":"Vickers","year":"2001","journal-title":"Nucleic Acid Res"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB30","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/5409","article-title":"Optimizing the impact of genomics on drug discovery and development","volume":"16(suppl)","author":"Crooke","year":"1998","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB31","series-title":"Antisense Drug Technology \u2013 Principles, Strategies and Applications","first-page":"119","article-title":"Pharmacokinetic properties in animals","author":"Geary","year":"2001"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB32","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/78475","article-title":"Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis","volume":"18","author":"Zhang","year":"2000","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S0958-1669(01)00270-1_BIB33","first-page":"388","article-title":"Pharmacokinetics and pharmacodynamics of an antisense phosphorothioate oligonucleotide targeting Fas mRNA in mice","volume":"296","author":"Yu","year":"2001","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Current Opinion in Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166901002701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0958166901002701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T02:29:04Z","timestamp":1556850544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0958166901002701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["S0958166901002701"],"URL":"https:\/\/doi.org\/10.1016\/s0958-1669(01)00270-1","relation":{},"ISSN":["0958-1669"],"issn-type":[{"type":"print","value":"0958-1669"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}